News Search Results
Sep 12, 2025, 10:00 ET INTERNATIONALLY RECOGNIZED MALARIA RESEARCHER STEFAN KAPPE, PHD, APPOINTED NEW DIRECTOR OF THE UM SCHOOL OF MEDICINE'S CENTER FOR VACCINE DEVELOPMENT AND GLOBAL HEALTH
engineer live attenuated Plasmodium parasites to develop safer and more effective malaria vaccines. Last year, his lab collaborated with biotechnology company
More news about: University of Maryland Medical Center
Sep 12, 2025, 09:52 ET Fermenta Granted Process Patent for Plant-Based Vitamin D3
contribute to global wellness." This milestone not only strengthens Fermenta's competitive moat but also diversifies its pioneering legacy in biotechnology and nutrition, supporting its vision to address global nutrition gaps while maintaining scientific excellence and sustainability leadership.
More news about: Fermenta Biotech Limited
Sep 12, 2025, 09:30 ET Shineco (SISI) Ignites Growth: $8.7M Tech Deal & Major Singapore Alliance Unleash Dual Engines
US$8.7 million with Xinke Future Biotechnology (Bazhou) Co., Ltd. for the research and development of "microalgae-derived extracellular vesicles" technology. Separately, a delegation from Singapore's leading biotechnology company, BICC, completed a productive site
More news about: Shineco,Inc.
Sep 12, 2025, 09:00 ET Alkermes Appoints Joshua Reed as Chief Financial Officer
brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics, a then publicly-traded biotechnology company. Prior to that, he was the CFO at Aldeyra Therapeutics. Earlier in his career,
More news about: Alkermes plc
Sep 12, 2025, 07:30 ET Origin Agritech Announces Appointment of Two New Independent Directors and Board Restructuring
agricultural industry knowledge and proven track record in leading major agricultural enterprises will be invaluable as we continue to expand our biotechnology seed pipeline and market presence. Mr. Hau's extensive financial expertise and corporate governance experience will strengthen our oversight capabilities
More news about: Origin Agritech Limited
Sep 12, 2025, 06:42 ET Weekly Recap: 12 Health Press Releases You Need to See
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment"Lilly
More news about: PR Newswire
Sep 12, 2025, 06:22 ET Weekly Recap: 9 Tech Press Releases You Need to See
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investmentEli
More news about: PR Newswire
Sep 12, 2025, 06:02 ET 13 Press Releases You Need to See This Week
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment"Lilly
More news about: PR Newswire
Sep 12, 2025, 00:35 ET Indication Expansion Accelerates: First Patient Dosed in Melanoma Phase 1b/II Trial of Opamtistomig
particularly for those with acral and mucosal subtypes. About Leads Biolabs Founded in 2012, Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies to address underserved medical needs in oncology,
More news about: Leads Biolabs
Sep 11, 2025, 12:02 ET Precision Medicine Market to Reach USD 103.73 Billion by 2035, with CAGR 11.3% Driven by Genomics, AI Integration, and Targeted Therapies - Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Sep 11, 2025, 10:00 ET Lilly to participate in Bernstein's 2nd Annual Healthcare Forum
life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges:
More news about: Eli Lilly and Company
Sep 11, 2025, 09:41 ET Gene Solutions Secures Patent(1) for Breakthrough Mitochondrial Therapy Platform Targeting Neurological Diseases
board member. "This achievement protects our proprietary inventions and strengthens our position as a collaborator of choice for pharmaceutical and biotechnology partners worldwide." With research expertise spanning the USA and UK, Gene Solutions is dedicated to accelerating
More news about: Gene Solutions
Sep 11, 2025, 09:27 ET GLOBAL FIRST "High-Definition Image": Decoding the "Code of Youth" - LivingPhoenix's POGMENT Collagen Breakthrough Fills Global Gap
of Tokyo, among other institutions, has passed peer review and was published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology (Impact Factor: 4.8). These milestones mark the technology's entry into a high-standard, high-barrier phase of development. The project
More news about: LivingPhoenix
Sep 11, 2025, 09:00 ET MycoWorks Reaches New Milestone with the Next Iteration of Fine Mycelium™
"mycelium-only" materials MycoWorks is at the forefront of transforming mycelium materials into industrial reality. The company's Fine Mycelium™ biotechnology has rapidly scaled into a platform for fast-paced innovation, building on years of pioneering achievements in mycology, manufacturing and tanning
More news about: MycoWorks
Sep 11, 2025, 08:44 ET SeoulTech Researchers Uncover High PAHs in Common Foods
making it safe, reliable, and efficient for PAH analysis. In a new study, a team of researchers from the Department of Food Science and Biotechnology, Seoul National University of Science and Technology, led by Professor Joon-Goo Lee,
More news about: Seoul National University of Science and Technology (SEOULTECH)
Sep 11, 2025, 08:30 ET Rare Disease Trials, Rarely Ready: Why Most Fail Before They Begin, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 11, 2025, 08:30 ET DNA-Encoded Library Data: Unlocking Chemomic Insights for Drug Discovery, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 11, 2025, 07:43 ET 世界初の「高精細画像」！「青春のコード」を解読--如鳳凰POGMENTコラーゲン成果が国際的空白を埋める
た、如鳳凰が上海交通大学医学院付属第九人民病院、国家老年医学中心北京病院、北京大学第三病院、および東京大学などの機関と共同で作成したオリジナル研究成果は、ピアレビューを経てSCI Q1領域の学術誌「Frontiers in Bioengineering and Biotechnology」（インパクトファクター4.8）に掲載されました。 さらに、本技術成果は国家薬品監督管理局の標準記録に承認され、「組織工学医療機器コラーゲン用語集」（YY/T1955-2025）に掲載、医療機器主要文書登録及び化粧品原料リストにも掲載されている。 将来的には、医療美容およびアンチエイジング、組織工学、慢性創傷治癒、機能性化粧品など多岐にわたるシーンにおいて応用が見込まれ、広範な産業化の展望を有している。
More news about: 如鳳凰
Sep 10, 2025, 15:07 ET Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
international interest rates, change in laws and regulations that apply to the Indian and global biotechnology and pharmaceuticals industries, increasing competition in and the conditions of the Indian and global biotechnology and pharmaceuticals industries, changes in political conditions in India
More news about: Biocon
Sep 10, 2025, 14:30 ET NeuroSense's Drug Candidate Shows Early Signals of Benefit in Alzheimer's Patient-Derived Neurons
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced positive initial results from its collaboration with
More news about: NeuroSense
Sep 10, 2025, 09:30 ET Shineco Achieves Mass Production of High-Purity Physical Phospholipids, Breaking Foreign Monopoly and Unlocking Innovation Across Industries
"Company"), a leading developer of induced pluripotent stem cell (iPSC) technology platforms, today announced that its subsidiary, Fuzhou Meidashan Biotechnology Co., Ltd., has successfully achieved large-scale production of high-purity, highly active free-form soybean phospholipids. This breakthrough was
More news about: Shineco,Inc.
Sep 10, 2025, 08:48 ET Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
Sep 10, 2025, 08:43 ET Lupin Receives U.S. FDA Approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity, the First Product from its Nanomi's Long-Acting Injectable Platform
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Limited
Sep 10, 2025, 08:30 ET Tumor Microenvironment Analysis Using Curated Data and Modeling, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks
Sep 10, 2025, 08:30 ET Patient Recruitment Strategies: Empowering Patients Through Accessible Information, Upcoming Webinar Hosted by Xtalks
the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access
More news about: Xtalks